We are live on ! Find out more
CRBP icon

Corbus Pharmaceuticals
CRBP

82 hedge funds and large institutions have $335M invested in Corbus Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

7,271% more capital invested

Capital invested by funds: $4.54M → $335M (+$330M)

1,633% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 3

150% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 6

141% more funds holding

Funds holding: 34 → 82 (+48)

64.31% more ownership

Funds ownership: 17.01% → 81.31% (+64%)

3% more call options, than puts

Call options by funds: $3.2M | Put options by funds: $3.09M

Holders
82
Holders Change
+48
Holders Change %
+141.18%
% of All Funds
1.18%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.04%
New
52
Increased
15
Reduced
6
Closed
3
Calls
$3.2M
Puts
$3.09M
Net Calls
+$107K
Net Calls Change
-$106K

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$49.9M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$17.3M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$10.2M
4
OCA
Octagon Capital Advisors
New York
+$9.99M
5
Citadel Advisors
Citadel Advisors
Florida
+$9.1M

Top Sellers

Rank Fund Capital Flow
1
SCM
Sio Capital Management
New York
-$906K
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$417K
3
Group One Trading
Group One Trading
Illinois
-$34.5K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$15.2K
5
Osaic Holdings
Osaic Holdings
Arizona
-$5.33K
Name Holding Trade Value Shares
Change 		Change in
Stake
DCM
26
Driehaus Capital Management
Illinois
$2.47M +$1.55M +63,059 New
JP Morgan Chase
27
JP Morgan Chase
New York
$2.42M +$1.5M +61,011 +11,236%
GTC
28
Ghost Tree Capital
New York
$2.23M +$1.4M +56,941 New
Hudson Bay Capital Management
29
Hudson Bay Capital Management
Connecticut
$1.69M +$1.06M +43,000 New
WP
30
Woodline Partners
California
$1.61M +$1.01M +40,981 New
HP
31
HealthInvest Partners
Sweden
$1.49M +$937K +38,000 New
State Street
32
State Street
Massachusetts
$1.41M +$562K +22,800 +173%
SFM
33
Sphera Funds Management
Israel
$1.37M +$863K +35,000 New
Jane Street
34
Jane Street
New York
$1.27M +$799K +32,400 New
SCM
35
Silverarc Capital Management
Massachusetts
$1.25M +$789K +31,980 New
Bank of America
36
Bank of America
North Carolina
$1.1M +$690K +27,991 +699,775%
Mirae Asset Global Investments
37
Mirae Asset Global Investments
South Korea
$976K +$614K +24,880 New
TD Asset Management
38
TD Asset Management
Ontario, Canada
$832K +$523K +21,200 New
Northern Trust
39
Northern Trust
Illinois
$785K +$493K +20,011 New
PCM
40
Prelude Capital Management
New York
$704K +$443K +17,946 New
Man Group
41
Man Group
United Kingdom
$693K +$436K +17,673 New
Dimensional Fund Advisors
42
Dimensional Fund Advisors
Texas
$631K -$15.2K -617 -4%
ACM
43
ADAR1 Capital Management
Texas
$628K +$395K +16,000 New
UBS Group
44
UBS Group
Switzerland
$607K +$373K +15,144 +4,718%
Citigroup
45
Citigroup
New York
$601K +$363K +14,741 +2,604%
Squarepoint
46
Squarepoint
New York
$601K +$377K +15,304 New
LIP
47
Lighthouse Investment Partners
Florida
$586K +$368K +14,943 New
HF
48
HRT Financial
New York
$483K +$304K +12,314 New
TI
49
Trexquant Investment
Connecticut
$470K +$296K +11,984 New
JFG
50
Jefferies Financial Group
New York
$436K +$274K +11,100 New
1
2
3 4

CRBP Hedge Fund Activity: Q1 2024 in Review

82 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Corbus Pharmaceuticals (CRBP) for Q1 2024, worth a combined $335M — up 7,271% from $4.54M a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new CRBP positions and 3 closed out — a net gain of 49 holders — while 15 added to existing stakes and 6 trimmed.

The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $49.9M. The largest seller was Sio Capital Management, exiting entirely with an estimated $906K sold.

  • 82 institutional investors held Corbus Pharmaceuticals (CRBP) as of Q1 2024, up from 34 in Q4 2023.
  • Funds reported $335M of Corbus Pharmaceuticals stock for Q1 2024, up 7,271% quarter-over-quarter.
  • 52 funds opened new Corbus Pharmaceuticals positions in Q1 2024 and 3 closed out, a net change of +49 holders.
  • The largest Corbus Pharmaceuticals buyer in Q1 2024 was Cormorant Asset Management, an estimated $49.9M added.
  • The largest Corbus Pharmaceuticals seller in Q1 2024 was Sio Capital Management, an estimated $906K sold.

Based on aggregated 13F filings for Q1 2024.